SEC Form 4 · accession 0001209191-18-025446
NEKTAR THERAPEUTICS · NKTR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roy A Whitfield
Director
Period of report
Apr 17, 2018
Accepted (ET)
Apr 18, 2018 · 6:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000906709
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 17, 2018 | M | 30,000 | $14.26 | A | 172,000 | D | |
| Common Stock | holding | — | — | — | 20,000 | I | by Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | $14.26 | Apr 17, 2018 | M | 30,000 | D | Sep 30, 2011 | Sep 14, 2018 | Common Stock | 30,000 | 0 | D |